You are here

  • Home
  • Archive
  • Volume 80, Issue 5
  • Correction: Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programme

Article metrics

Article menu

See original article:

Download PDFPDF
Miscellaneous
Correction: Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programme

 

Online download statistics by month:

Online download statistics by month: April 2021 to March 2024

AbstractFullPdf
Apr 20215513116
May 20211793723
Jun 202131299
Jul 20212184
Aug 2021573318
Sep 202120149
Oct 2021350155
Nov 2021446157
Dec 2021214215
Jan 2022170115
Feb 202231583
Mar 2022309105
Apr 2022137135
May 202213387
Jun 2022107137
Jul 202292101
Aug 2022115136
Sep 202212592
Oct 2022149154
Nov 20227971
Dec 202261154
Jan 20234942
Feb 202311241
Mar 20237073
Apr 20232861
May 20234261
Jun 20237483
Jul 20233032
Aug 20233831
Sep 20231531
Oct 20233111
Nov 20234330
Dec 20234830
Jan 20243500
Feb 20244210
Mar 20242631
Total4344390163